-+ 0.00%
-+ 0.00%
-+ 0.00%

AZALOX MDS study advances to final Phase 1b cohort-SNT.AX

ASX·07/20/2026 00:01:54

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.